Rainbow Children's Medicare Limited has responded to an inquiry from BSE Limited regarding significant movement in the trading volume of its securities. The company submitted its clarification on April 8, 2026, addressing concerns raised by the stock exchange about unusual trading activity.

Regulatory Compliance Confirmation

The healthcare provider confirmed its adherence to regulatory requirements in its response to BSE. The company stated that it remains in full compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rainbow Children's Medicare emphasized that it has been regularly disseminating all material information and events that may impact its operations or performance to the stock exchanges.

Key Declarations

The company made several important declarations in its clarification to the exchange:

• No undisclosed material information or impending announcements that could affect price or volume behavior
• No unpublished price sensitive information (UPSI) withheld from stock exchanges
• No awareness of undisclosed information that could explain recent trading volume movement

Market-Driven Activity

Rainbow Children's Medicare attributed the volume movement to market-driven factors rather than any company-specific developments. The management stated that the trading activity appears to be driven by prevailing market conditions and investor sentiment, rather than any information or events within the company's knowledge that would require regulatory disclosure.

Corporate Information

The company reiterated its commitment to ensuring timely, adequate and accurate disclosures in accordance with applicable regulatory requirements. Rainbow Children's Medicare stated it will continue to disclose any material developments as and when they arise, maintaining transparency with stakeholders and regulatory authorities.

Rainbow Children's Medicare Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The healthcare company filed the mandatory compliance documentation with stock exchanges on April 6, 2026, fulfilling regulatory requirements for listed entities.

Regulatory Filing Details

The compliance certificate was filed under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Shreya Mitra digitally signed and submitted the documentation to both major stock exchanges where the company's shares are listed.

Registrar Confirmation

KFIN Technologies Limited, acting as the company's Registrar and Share Transfer Agent, provided the necessary compliance certificates. Senior Manager Vijayashailu J E N signed separate certificates for both depositories on April 1, 2026.

The registrar confirmed that details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, were properly furnished to all stock exchanges where Rainbow Children's Medicare shares are listed, as required under SEBI regulations.

Depository Communications

KFIN Technologies issued compliance certificates to both major depositories:

• NSDL (National Securities Depository Limited) - Certificate reference KFIN/RCMP/NSDL/74(5) E/1
• CDSL (Central Depository Services India Limited) - Certificate reference KFIN/RCMP/CDSL/74(5) E/1

Both certificates were dated April 1, 2026, and confirmed compliance with SEBI's dematerialization and rematerialization reporting requirements for the specified quarter.

Corporate Information

Rainbow Children's Medicare Limited operates from its registered office in Banjara Hills, Hyderabad, with CIN L85110TG1998PLC029914. The company maintains its corporate office at Daulet Arcade, also located in Banjara Hills, Hyderabad. This quarterly compliance filing demonstrates the company's adherence to regulatory requirements and corporate governance standards mandated by SEBI for listed healthcare entities.